Exploiting morphology and texture of 3D tumor models in DTI for differentiating glioblastoma multiforme from solitary metastasis
Συγγραφέας
Vamvakas A., Tsougos I., Arikidis N., Kapsalaki E., Fountas K., Fezoulidis I., Costaridou L.Ημερομηνία
2018Γλώσσα
en
Λέξη-κλειδί
Επιτομή
Ambiguous imaging appearance of Glioblastoma Multiforme (GBM) and solitary Metastasis (MET) is a challenge to conventional Magnetic Resonance Imaging (MRI) based diagnosis, leading to exploitation of advanced MRI techniques, such as Diffusion Tensor Imaging (DTI). In this study, 3D tumor models are generated by a DTI clustering segmentation technique, providing up to 16 brain tissue diffusivities, complemented by T1 post-contrast imaging, resulting in the identification of tumor core, whose surface is refined by a Morphological Morphing interpolation technique. The 3D models are analyzed in terms of their surface and internal signal variations characteristics towards identification of discriminant features for differentiation between GBMs and METs, utilizing a case sample composed of 10 GBMs and 10 METs. Morphology analysis of tumor core surface is assessed by 5 local curvature features. Texture analysis considers 11 first and 16 second order 3D textural features. From the 16 second order features, 11 are based on Gray Level Co-Occurrence Matrices (GLCM) and 5 on Gray Level Run Length Matrices (GLRLM), calculated from DTI isotropic and anisotropic parametric maps, corresponding to 3D tumor core segmented from the clustering technique. Also, 3 different image quantization levels (QL) were tested for both GLCM and GLRLM analysis, while 1–4 pixel displacements (D) in case of GLCM analysis. Case sample distributions of morphology and texture features were analyzed using the Mann-Whitney U test, with a cut-off value of 0.05 to identify discriminant features. The discriminatory performance of the derived features was analyzed with Receiver Operating Characteristic (ROC) curve analysis. Results highlight the value of all 5 local curvature descriptors to capture differences between the boundary of GBMs and METs. Histogram analysis of isotropy maps revealed statistical significant differences for median value and kurtosis, while 7 out of the 11 GLCM features were capable of discriminating heterogeneity of anisotropic diffusion properties of GBMs and METs, at QL = 6 and D = 2. Finally, all 5 GLRLM features extracted from diffusion isotropy maps seem to discriminate structural properties of GBMs and METs, at QL = 5. Results demonstrate the potential of surface morphology and texture analysis of 3D tumor imaging appearance in pre-treatment brain MRI tumor differentiation. © 2018 Elsevier Ltd
Collections
Related items
Showing items related by title, author, creator and subject.
-
The role of MiRNA-21 in gliomas: Hope for a novel therapeutic intervention?
Aloizou A.-M., Pateraki G., Siokas V., Mentis A.-F.A., Liampas I., Lazopoulos G., Kovatsi L., Mitsias P.D., Bogdanos D.P., Paterakis K., Dardiotis E. (2020)Gliomas are the most common primary brain tumors in adults. They are generally very resistant to treatment and are therefore associated with negative outcomes. MicroRNAs (miRNAs) are small, non-coding RNA molecules that ... -
Lapatinib with whole brain radiotherapy in patients with brain metastases from breast and non-small cell lung cancer: a phase II study of the Hellenic Cooperative Oncology Group (HeCOG)
Christodoulou C., Kalogera-Fountzila A., Karavasilis V., Kouvatseas G., Papandreou C.N., Samantas E., Varaki K., Papadopoulos G., Bobos M., Rallis G., Razis E., Goudopoulou A., Kalogeras K.T., Syrigos K.N., Fountzilas G. (2017)Small molecules, mainly tyrosine kinase inhibitors, are currently used in various malignancies. Lapatinib, a dual inhibitor of EGFR/HER2 tyrosine kinases, has demonstrated effectiveness in brain metastases from HER2-overexpressing ... -
Benign intracranial lesions-radiotherapy: An overview of treatment options, indications and therapeutic results
Tzikoulis V., Gkantaifi A., Alongi F., Tsoukalas N., Saraireh H.H., Charalampakis N., Tzikoulis G., Andreou E., Tsapakidis K., Kardamakis D., Tsanadis K., Kyrgias G., Tolia M. (2020)Background: Radiation Therapy (RT) is an established treatment option for benign intracranial lesions. The aim of this study is to display an update on the role of RT concerning the most frequent benign brain lesions and ...